Edition:
United Kingdom

People: Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.98EUR
4:35pm BST
Change (% chg)

€0.04 (+1.36%)
Prev Close
€2.94
Open
€2.94
Day's High
€2.98
Day's Low
€2.92
Volume
6,619
Avg. Vol
42,615
52-wk High
€3.38
52-wk Low
€2.57

Quemeneur, Eric 

Dr. Eric Quemeneur, Ph.D., has been Executive Vice President, Director of Research & Development and Member of the Management Committee at Transgene since 2014. Before joining Transgene he served as Director of Programs and Reclamation in the Life Sciences Department of the CEA, after a 20-year career in that organization. His responsibilities included managing the Research and Development programs and transferring them into applications, leading multi-disciplinary teams and developing national and international alliances. He is a biochemical engineer, INSA Lyon (1986), with a PhD in science, a D.U. degree in Industrial Pharmaceuticals from Universite Claude Bernard Lyon 1 and a Certificate in Research Management from Universite Pierre et Marie Curie – Paris VI. He is the author of some 80 publications in international scientific journals.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --